Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 1
Submit an article Journal homepage
32
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Primary Treatment of Low-grade Non-Hodgkin's Lymphoma with the Combination of Fludarabine and Mitoxantrone: A Phase II Study of the Hellenic Cooperative Oncology Group

Meletios A. Dimopoulos Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece
,
George Fountzilas AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
,
Efstathios Papageorgiou Second Department of Internal Medicine, University of Athens School of Medicine Athens, Athens, Greece
,
Christos Kiamouris Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece
,
George Mantzios Second Department of Internal Medicine, University of Athens School of Medicine Athens, Athens, Greece
,
Athanassios Anagnostopoulos Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece
,
Costas Nicolaides Department of Medical Oncology, University of Ioannina School of Medicine, Ioannina, Greece
&
Theofanis Economopoulos Second Department of Internal Medicine, University of Athens School of Medicine Athens, Athens, Greece
 show all
Pages 111-114 | Published online: 01 Jul 2009

  • Hochstor, H.S., Kim. K. and Gree. M.D. (1992) "Acitivity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: Results of an Eastern Cooperative Oncology Group study", Journal of Clinical Oncology 10, 28-32.
  • Redman, J.R., Cabanillas, F. and Wellasquez, W.S. (1992) "Phase II trial of fludarabine phosphate in lymphoma", Journal of Clinical Oncology 10, 790-794.
  • Zinzani, P.L. Lauria, F. and Rondelli, D. (1993) "Fludarabine: an active agent in the treatment of previously treated and untreated low-grade non-Hodgkin's lymphoma", Annals of Oncology 4, 575-578.
  • Solal-Celigny, P., Brice. P., Brousse, N., Caspard, H., Bation, Y., Haionn. C., Bosly. A., Tilly, H., Bordessoule, D., Sebbanc, Harousspan, J.L., Morel, P., Dupas, B., Plassart, F., Vasile, N., Fort, N. and Leporrier, M. (1996) "Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: A multicentre study by the group d'Etude des lymphomes de I' Adulte", Journal of Clinical Oncology 14, 514-519.
  • Mclaughlin, P., Hagemeister, F.B., Sawn, F., Cabanillas, F., Pate, O., Romaguera, J.E., Rodriguez, M.A., Redman, J.R, and Keating, M. (1994) "Phase I study of the combination of fludarabine, mitoxantrone and dexamethasone in low-grade lymphoma", Journal of Clinical Oncology 12, 575-579.
  • McLaughlin, P., Hagemeister, F.B., Romaguera, J.E., Sarris, A.H., Pate, O., Younes, A., Swan, F., Kesting, M. and Cabanillas, F. (1996) "Fludarabine mitoxantrone and dexamethasona: an effective new regimen for indolent lymphoma", Journal of Clinical Oncology 14, 1262-1268.
  • Emmanouillides, C., Rosen, P., Rasti, S., Territo, M. and Kunkel, L., (1998) "Treatment of indolent lymphoma with fludarabine/mitoxantrone combination : a phase II trial", Hematological Oncology 16, 107-116.
  • Zinzani. P.L., Maganoli, M., Bendandi, M., Gherlinzoni, F., Orcioni, G.F., Cellini, C., Stefoni, V., Pileri, S.A. and Tura, S. (2000) "Efficacy of fludarabine and mitoxantrone combination regiment in untreated indolent non-Hodgkin's lymphomas", Annals of Oncology 11, 363-365.
  • Crawley, C. R., Foran, J.M., Gupta, R.K., Rohatiner, A.Z., Summers, K., Mathews, J., Micallef, I.N., Radford, J.A., Johnson, S.A., Johnson, P.W., Sweetenham, J.W. and Lister, T.A. (2000) "A phase II study to evaluate the combination of fludarabine, mitoxantrone and dexamethasone in patients with follicular lymphoma", Annuals of Oncology 11, 861-865.
  • Zinzani, P.L., Magagnoli, M., Morelli, L., De Renzo, A., Battista R., Zaccaria, A., Guargigni, L., Stefoni, V., Ricciuti, F., Gobbi, M. and Tura, S. (2000) "Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma". Jounral of Clinical Oncology 18, 773-779.
  • Flinn, I.W., Byrd, J.C., Morricon, C., Jamission, J., Diehl, L.F., Murphy, T., Piantadosi, S., Sieffer, E., Ambinder, R.F., Vogelsang, G. and Grever, M.R. (2000) "Fludarabine and cyclophosphiamide with filgrastim support in patients with previously untreated indolent lymphoid malingancies", Blood 96, 71-75.
  • Miller, A. B., Hoogstraten, B., Staquet, M. and Winkler, A. (1981) "Reporting results of cancer treatment", Cancer 47, 207-214.
  • McLaughlin, P., Hagemeister, F.B., Rodriguez, M. A., Sarrism A. H., Pate, O., Younes, A., Lee, M.S., Dang, N.H., Romaguers, J.E., Preti, A.H., McAda, N. and Cabanillas, F. (2000) "Safety of fludarabine, mitoxanirone and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma", Seminars in Oncology 27(Suppl. 12), 37-41.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.